175 related articles for article (PubMed ID: 37711899)
21. Quality of life of sarcoma patients from diagnosis to treatments: predictors and longitudinal trajectories.
Paredes T; Pereira M; Moreira H; Simões MR; Canavarro MC
Eur J Oncol Nurs; 2011 Dec; 15(5):492-9. PubMed ID: 21306951
[TBL] [Abstract][Full Text] [Related]
22. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
[TBL] [Abstract][Full Text] [Related]
23.
Soomers V; Desar IM; van de Poll-Franse LV; Husson O; van der Graaf WT
BMJ Open; 2020 Oct; 10(10):e039309. PubMed ID: 33109665
[TBL] [Abstract][Full Text] [Related]
24. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in very elderly radiotherapy patients: a prospective pilot study using the EORTC QLQ-ELD14 module.
Kaufmann A; Schmidt H; Ostheimer C; Ullrich J; Landenberger M; Vordermark D
Support Care Cancer; 2015 Jul; 23(7):1883-92. PubMed ID: 25475738
[TBL] [Abstract][Full Text] [Related]
26. ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review.
Andritsch E; Beishon M; Bielack S; Bonvalot S; Casali P; Crul M; Delgado Bolton R; Donati DM; Douis H; Haas R; Hogendoorn P; Kozhaeva O; Lavender V; Lovey J; Negrouk A; Pereira P; Roca P; de Lempdes GR; Saarto T; van Berck B; Vassal G; Wartenberg M; Yared W; Costa A; Naredi P
Crit Rev Oncol Hematol; 2017 Feb; 110():94-105. PubMed ID: 28109409
[TBL] [Abstract][Full Text] [Related]
27. The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.
Cheng JX; Liu BL; Zhang X; Zhang YQ; Lin W; Wang R; Zhang YQ; Zhang HY; Xie L; Huo JL
BMC Med Res Methodol; 2011 Apr; 11():56. PubMed ID: 21513533
[TBL] [Abstract][Full Text] [Related]
28. Does it matter how we evaluate HRQOL? Longitudinal comparison of the EORTC QLQ-C30/QLQ-OG25 and FACT-E.
Darling GE; Sulman J; Espin-Garcia O; Trudel JG; Atenafu EG; Kidane B
J Cancer Surviv; 2021 Aug; 15(4):641-650. PubMed ID: 33106994
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.
Gjorup CA; Groenvold M; Hendel HW; Dahlstroem K; Drzewiecki KT; Klausen TW; Hölmich LR
Eur J Cancer; 2017 Nov; 85():122-132. PubMed ID: 28918186
[TBL] [Abstract][Full Text] [Related]
30. Anxiety, depression, health-related quality of life, and mortality among colorectal patients: 5-year follow-up.
Orive M; Anton-Ladislao A; Lázaro S; Gonzalez N; Bare M; Fernandez de Larrea N; Redondo M; Bilbao A; Sarasqueta C; Aguirre U; Quintana JM;
Support Care Cancer; 2022 Oct; 30(10):7943-7954. PubMed ID: 35737143
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of 51 cases with rare childhood soft tissue sarcomas].
Cai MX; Pan C; Ye QD; Zhou M; Gao YJ; Hu WT; Tang JY
Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):917-922. PubMed ID: 27938592
[No Abstract] [Full Text] [Related]
32. Changes in health-related quality of life among gynecologic cancer survivors during the two years after initial treatment: a longitudinal analysis.
Zandbergen N; de Rooij BH; Vos MC; Pijnenborg JMA; Boll D; Kruitwagen RFPM; van de Poll-Franse LV; Ezendam NPM
Acta Oncol; 2019 May; 58(5):790-800. PubMed ID: 30698069
[No Abstract] [Full Text] [Related]
33. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
[TBL] [Abstract][Full Text] [Related]
34. Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy.
Hong F; Bosco JL; Bush N; Berry DL
BMC Cancer; 2013 Mar; 13():165. PubMed ID: 23537330
[TBL] [Abstract][Full Text] [Related]
35. Income and health-related quality of life among prostate cancer patients over a one-year period after radical prostatectomy: a linear mixed model analysis.
Klein J; Lüdecke D; Hofreuter-Gätgens K; Fisch M; Graefen M; von dem Knesebeck O
Qual Life Res; 2017 Sep; 26(9):2363-2373. PubMed ID: 28444552
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
Coens C; Suciu S; Chiarion-Sileni V; Grob JJ; Dummer R; Wolchok JD; Schmidt H; Hamid O; Robert C; Ascierto PA; Richards JM; Lebbé C; Ferraresi V; Smylie M; Weber JS; Maio M; Bottomley A; Kotapati S; de Pril V; Testori A; Eggermont AMM
Lancet Oncol; 2017 Mar; 18(3):393-403. PubMed ID: 28162999
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study.
Motzer R; Porta C; Alekseev B; Rha SY; Choueiri TK; Mendez-Vidal MJ; Hong SH; Kapoor A; Goh JC; Eto M; Bennett L; Wang J; Pan JJ; Saretsky TL; Perini RF; He CS; Mody K; Cella D
Lancet Oncol; 2022 Jun; 23(6):768-780. PubMed ID: 35489363
[TBL] [Abstract][Full Text] [Related]
38. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
39. The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study.
de Mol M; Visser S; Aerts J; Lodder P; van Walree N; Belderbos H; den Oudsten B
BMC Cancer; 2020 May; 20(1):431. PubMed ID: 32423432
[TBL] [Abstract][Full Text] [Related]
40. eCross-cultural adaptation of the spine oncology-specific SOSGOQ2.0 questionnaire to German language and the assessment of its validity and reliability in the clinical setting.
Datzmann T; Kisel W; Kramer J; Dreimann M; Müller-Broich JD; Netzer C; Schaser KD; Schmitt J; Disch AC;
BMC Cancer; 2021 Sep; 21(1):1044. PubMed ID: 34556063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
